Literature DB >> 22453627

The role of assistive technology in self-perceived participation.

Jacquie D Ripat1, Roberta L Woodgate.   

Abstract

The aim of this study was to develop an understanding of how assistive technology (AT) contributes to self-perceived participation for individuals with spinal cord injuries and to propose a revised definition of AT in light of the findings. A grounded theory study of 19 adults with spinal cord injuries was conducted. Participants engaged in individual in-depth interviews and took photographs of the role of AT in their own environments. Analysis consisted of an inductive process of constant comparison. Participants attended a follow-up focus group intended to verify and contribute to the credibility of the findings. The primary theme identified was AT as a means to participation. Three categories served to identify the decision-making processes that individuals underwent to select AT that would promote positive participation experiences: inclusion versus autonomy and accomplishment, availability and cost and contexts of use. A new definition of AT was proposed; this definition identifies AT as a means to enable occupation, emphasizes the relevance of the environment and highlights the importance placed on self-perceived participation. AT recommendations must be based on a thorough understanding of the role that AT plays in the lives of clients. Future research will further develop and validate the definition proposed in this study.

Entities:  

Mesh:

Year:  2012        PMID: 22453627     DOI: 10.1097/MRR.0b013e3283531806

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  8 in total

1.  Factors contributing to defaulting scheduled therapy sessions by caregivers of children with congenital disabilities.

Authors:  A Nota; T M Chikwanha; J January; N Dangarembizi
Journal:  Malawi Med J       Date:  2015-03       Impact factor: 0.875

2.  Experience and Utility of Using the Participatory Research Method, Photovoice, in Individuals With Spinal Cord Injury.

Authors:  Sherri L LaVela; Salva Balbale; Jennifer N Hill
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018-02-12

3.  Starting a new conversation: Engaging Veterans with spinal cord injury in discussions of what function means to them, the barriers/facilitators they encounter, and the adaptations they use to optimize function.

Authors:  Jennifer N Hill; Salva Balbale; Keshonna Lones; Sherri L LaVela
Journal:  Disabil Health J       Date:  2016-06-21       Impact factor: 2.554

Review 4.  Computer assistive technology and associations with quality of life for individuals with spinal cord injury: a systematic review.

Authors:  Valéria Baldassin; Helena Eri Shimizu; Emerson Fachin-Martins
Journal:  Qual Life Res       Date:  2018-02-07       Impact factor: 4.147

5.  Assistive Technology Use and Provision During COVID-19: Results From a Rapid Global Survey.

Authors:  Emma M Smith; Maria Luisa Toro Hernandez; Ikenna D Ebuenyi; Elena V Syurina; Giulia Barbareschi; Krista L Best; Jamie Danemayer; Ben Oldfrey; Nuha Ibrahim; Catherine Holloway; Malcolm MacLachlan
Journal:  Int J Health Policy Manag       Date:  2022-06-01

Review 6.  Understanding the participation outcomes for persons with disability when partnered with assistance dogs: A scoping review.

Authors:  Nicola Futeran; Lynette Mackenzie; Sarah Wilkes-Gillan; Claire Dickson
Journal:  Aust Occup Ther J       Date:  2022-04-25       Impact factor: 1.757

7.  The impact of the World Health Organization 8-steps in wheelchair service provision in wheelchair users in a less resourced setting: a cohort study in Indonesia.

Authors:  Maria L Toro; Chika Eke; Jonathan Pearlman
Journal:  BMC Health Serv Res       Date:  2016-01-22       Impact factor: 2.655

8.  Network analysis of assistive technology stakeholders in Malawi.

Authors:  Emma M Smith; Ikenna D Ebuenyi; Juba Kafumba; Monica Jamali-Phiri; Alister Munthali; Malcolm MacLachlan
Journal:  Glob Health Action       Date:  2022-12-31       Impact factor: 2.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.